Amgen - Biotech company impressed with strong pipeline!

Business Driver: Amgen (AMGN) is well-positioned in key segments with its core brand portfolio, covering high-margin key areas such as oncology, inflammatory diseases, osteoporosis, and more. With a solid portfolio that includes well-known blockbusters like Aimovig (migraine), Prolia (osteoporosis), and oncology products like XGEVA (bone marrow cancer, multiple myeloma), the leukemia drug Blincyto, and Kyprolis (multiple myeloma), as well as a well-filled drug pipeline, interesting growth opportunities are emerging in the medium term. On November...